Human papillomavirus infection predicts a better survival rate in patients with oropharyngeal cancer
CONCLUSIONS: Our data show that HPV infection is a predictor of better disease-free and overall survival in patients with oropharyngeal cancer. For HPV-positive oropharyngeal cancer patients weekly given cisplatin with concurrent radiotherapy can be an alternative to three weekly given cisplatin considering effectiveness and early toxicity.PMID:34522260 | PMC:PMC8425231 | DOI:10.5114/aoms.2019.83658
Source: Archives of Medical Science - Category: Biomedical Science Authors: Piotr K ędzierawski Anna Huruk-Kuchinka Agnieszka Radowicz-Chil Ryszard M ężyk Zdzis ława Rugała Jacek Sadowski Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Genital Warts | Head and Neck Cancer | HPV Testing | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Science | Skin Cancer | Smokers | Squamous Cell Carcinoma | Statistics | Toxicology